Actively Recruiting

Phase Not Applicable
Age: 7Years - 18Years
All Genders
NCT06907914

Schroth and Scapular Muscle Activation in Hyperkyphosis

Led by Istanbul University - Cerrahpasa · Updated on 2025-10-01

56

Participants Needed

1

Research Sites

58 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized controlled trial aims to investigate the effects of Schroth exercises on scapular muscle activation in children with thoracic hyperkyphosis. A total of 56 participants will be randomly assigned to either the Schroth exercise group or the control group receiving postural education. The intervention group will complete an 8-week supervised Schroth program focusing on three-dimensional correction, rotational breathing, and postural awareness. Primary outcome is scapular muscle activation measured by surface EMG. Secondary outcomes include muscle strength, scapular endurance, kyphotic appearance, posture, and pain. The results will guide clinical management and preventive strategies for children with postural thoracic hyperkyphosis.

CONDITIONS

Official Title

Schroth and Scapular Muscle Activation in Hyperkyphosis

Who Can Participate

Age: 7Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Thoracic kyphosis angle (Cobb) between �3e40�b0 and <70�b0 on lateral radiographs
  • Aged 7-18 years
  • Risser stage 0-5, indicating ongoing skeletal development
Not Eligible

You will not qualify if you...

  • Congenital or rigid spinal deformities/anomalies
  • Major musculoskeletal surgery or trauma, especially involving the spine
  • Physiotherapeutic intervention for the spine in the last 6 months
  • Current brace use
  • BMI �3e= 30
  • Regular upper extremity sports involvement (e.g., swimming, volleyball) at least twice a week for one year
  • More than 60 minutes of moderate-to-high intensity physical activity per week
  • Visual impairments or light sensitivity
  • Positive vestibular (Unterberger) test
  • Hearing impairments
  • Cognitive difficulties affecting comprehension
  • Systemic diseases (diabetes, hypothyroidism, infection, malignancy)
  • Neurological disorders
  • Active rheumatic diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Istanbul University-Cerrahpasa

Istanbul, Istanbul, Turkey (Türkiye)

Actively Recruiting

Loading map...

Research Team

K

Kübra Kardeş, PhD

CONTACT

T

Turgut Akgül, Prof

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here